 | • レポートコード：MRC2-11QY04797 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は結核診断のグローバル市場について調査・分析したレポートです。種類別（X線撮影法、診断検査法、核酸検査、ファージアッセイ、潜伏感染の検出、サイトカイン検出アッセイ、薬剤耐性の検出、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別結核診断の競争状況、市場シェア ・世界の結核診断市場：種類別市場規模 2015年-2020年（X線撮影法、診断検査法、核酸検査、ファージアッセイ、潜伏感染の検出、サイトカイン検出アッセイ、薬剤耐性の検出、その他） ・世界の結核診断市場：種類別市場規模予測 2021年-2026年（X線撮影法、診断検査法、核酸検査、ファージアッセイ、潜伏感染の検出、サイトカイン検出アッセイ、薬剤耐性の検出、その他） ・世界の結核診断市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界の結核診断市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米の結核診断市場分析：米国、カナダ ・ヨーロッパの結核診断市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの結核診断市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の結核診断市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの結核診断市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Laboratories、Abbott、Becton Dickinson and Company、bioMrieux、Cepheid、F. Hoffman La Roche、Hain Lifescience、Hologic Corporation、Thermo Fisher Scientific、Qiagen ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
TB is an infectious bacterial disease caused by Mycobacterium tuberculosis. It is communicable and can be transmitted from one person to another. TB is one of the world’s deadliest communicable diseases. In 2013, there were 9 million new TB cases and 1.5 million TB deaths, out of which 1.1 million among HIV-negative people and 0.4 million among HIV-positive people.
The tuberculosis diagnostics kit has undergone tremendous technological advancement to give better accuracy, quick results, and available at low cost. For the purpose of this study, the global tuberculosis diagnostics market is segmented into test types which includes radiographic methods, laboratory methods, nucleic acid testing, phage assay, cytokine detection test, detection of drug resistance, and Mantoux test.
Market Analysis and Insights: Global TB Diagnostic Market
The global TB Diagnostic market size is projected to reach US$ 2040.3 million by 2026, from US$ 1954.9 million in 2020, at a CAGR of 3.9%% during 2021-2026.
Global TB Diagnostic Scope and Market Size
TB Diagnostic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global TB Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Laboratories
Abbott
Becton Dickinson and Company
bioMrieux
Cepheid
F. Hoffman La Roche
Hain Lifescience
Hologic Corporation
Thermo Fisher Scientific
Qiagen
Market segment by Type, the product can be split into
Radiographic Method
Diagnostic Laboratory Methods
Nucleic Acid Testing
Phage Assay
Detection of Latent Infection
Cytokine Detection Assay
Detection of Drug Resistance
Others
Market segment by Application, split into
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by TB Diagnostic Revenue
1.4 Market by Type
1.4.1 Global TB Diagnostic Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Radiographic Method
1.4.3 Diagnostic Laboratory Methods
1.4.4 Nucleic Acid Testing
1.4.5 Phage Assay
1.4.6 Detection of Latent Infection
1.4.7 Cytokine Detection Assay
1.4.8 Detection of Drug Resistance
1.4.9 Others
1.5 Market by Application
1.5.1 Global TB Diagnostic Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global TB Diagnostic Market Perspective (2015-2026)
2.2 Global TB Diagnostic Growth Trends by Regions
2.2.1 TB Diagnostic Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 TB Diagnostic Historic Market Share by Regions (2015-2020)
2.2.3 TB Diagnostic Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 TB Diagnostic Market Growth Strategy
2.3.6 Primary Interviews with Key TB Diagnostic Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top TB Diagnostic Players by Market Size
3.1.1 Global Top TB Diagnostic Players by Revenue (2015-2020)
3.1.2 Global TB Diagnostic Revenue Market Share by Players (2015-2020)
3.1.3 Global TB Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global TB Diagnostic Market Concentration Ratio
3.2.1 Global TB Diagnostic Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by TB Diagnostic Revenue in 2019
3.3 TB Diagnostic Key Players Head office and Area Served
3.4 Key Players TB Diagnostic Product Solution and Service
3.5 Date of Enter into TB Diagnostic Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global TB Diagnostic Historic Market Size by Type (2015-2020)
4.2 Global TB Diagnostic Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global TB Diagnostic Market Size by Application (2015-2020)
5.2 Global TB Diagnostic Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America TB Diagnostic Market Size (2015-2020)
6.2 TB Diagnostic Key Players in North America (2019-2020)
6.3 North America TB Diagnostic Market Size by Type (2015-2020)
6.4 North America TB Diagnostic Market Size by Application (2015-2020)
7 Europe
7.1 Europe TB Diagnostic Market Size (2015-2020)
7.2 TB Diagnostic Key Players in Europe (2019-2020)
7.3 Europe TB Diagnostic Market Size by Type (2015-2020)
7.4 Europe TB Diagnostic Market Size by Application (2015-2020)
8 China
8.1 China TB Diagnostic Market Size (2015-2020)
8.2 TB Diagnostic Key Players in China (2019-2020)
8.3 China TB Diagnostic Market Size by Type (2015-2020)
8.4 China TB Diagnostic Market Size by Application (2015-2020)
9 Japan
9.1 Japan TB Diagnostic Market Size (2015-2020)
9.2 TB Diagnostic Key Players in Japan (2019-2020)
9.3 Japan TB Diagnostic Market Size by Type (2015-2020)
9.4 Japan TB Diagnostic Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia TB Diagnostic Market Size (2015-2020)
10.2 TB Diagnostic Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia TB Diagnostic Market Size by Type (2015-2020)
10.4 Southeast Asia TB Diagnostic Market Size by Application (2015-2020)
11 India
11.1 India TB Diagnostic Market Size (2015-2020)
11.2 TB Diagnostic Key Players in India (2019-2020)
11.3 India TB Diagnostic Market Size by Type (2015-2020)
11.4 India TB Diagnostic Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America TB Diagnostic Market Size (2015-2020)
12.2 TB Diagnostic Key Players in Central & South America (2019-2020)
12.3 Central & South America TB Diagnostic Market Size by Type (2015-2020)
12.4 Central & South America TB Diagnostic Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview
13.1.3 Abbott Laboratories TB Diagnostic Introduction
13.1.4 Abbott Laboratories Revenue in TB Diagnostic Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 Abbott
13.2.1 Abbott Company Details
13.2.2 Abbott Business Overview
13.2.3 Abbott TB Diagnostic Introduction
13.2.4 Abbott Revenue in TB Diagnostic Business (2015-2020)
13.2.5 Abbott Recent Development
13.3 Becton Dickinson and Company
13.3.1 Becton Dickinson and Company Company Details
13.3.2 Becton Dickinson and Company Business Overview
13.3.3 Becton Dickinson and Company TB Diagnostic Introduction
13.3.4 Becton Dickinson and Company Revenue in TB Diagnostic Business (2015-2020)
13.3.5 Becton Dickinson and Company Recent Development
13.4 bioMrieux
13.4.1 bioMrieux Company Details
13.4.2 bioMrieux Business Overview
13.4.3 bioMrieux TB Diagnostic Introduction
13.4.4 bioMrieux Revenue in TB Diagnostic Business (2015-2020)
13.4.5 bioMrieux Recent Development
13.5 Cepheid
13.5.1 Cepheid Company Details
13.5.2 Cepheid Business Overview
13.5.3 Cepheid TB Diagnostic Introduction
13.5.4 Cepheid Revenue in TB Diagnostic Business (2015-2020)
13.5.5 Cepheid Recent Development
13.6 F. Hoffman La Roche
13.6.1 F. Hoffman La Roche Company Details
13.6.2 F. Hoffman La Roche Business Overview
13.6.3 F. Hoffman La Roche TB Diagnostic Introduction
13.6.4 F. Hoffman La Roche Revenue in TB Diagnostic Business (2015-2020)
13.6.5 F. Hoffman La Roche Recent Development
13.7 Hain Lifescience
13.7.1 Hain Lifescience Company Details
13.7.2 Hain Lifescience Business Overview
13.7.3 Hain Lifescience TB Diagnostic Introduction
13.7.4 Hain Lifescience Revenue in TB Diagnostic Business (2015-2020)
13.7.5 Hain Lifescience Recent Development
13.8 Hologic Corporation
13.8.1 Hologic Corporation Company Details
13.8.2 Hologic Corporation Business Overview
13.8.3 Hologic Corporation TB Diagnostic Introduction
13.8.4 Hologic Corporation Revenue in TB Diagnostic Business (2015-2020)
13.8.5 Hologic Corporation Recent Development
13.9 Thermo Fisher Scientific
13.9.1 Thermo Fisher Scientific Company Details
13.9.2 Thermo Fisher Scientific Business Overview
13.9.3 Thermo Fisher Scientific TB Diagnostic Introduction
13.9.4 Thermo Fisher Scientific Revenue in TB Diagnostic Business (2015-2020)
13.9.5 Thermo Fisher Scientific Recent Development
13.10 Qiagen
13.10.1 Qiagen Company Details
13.10.2 Qiagen Business Overview
13.10.3 Qiagen TB Diagnostic Introduction
13.10.4 Qiagen Revenue in TB Diagnostic Business (2015-2020)
13.10.5 Qiagen Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. TB Diagnostic Key Market Segments
Table 2. Key Players Covered: Ranking by TB Diagnostic Revenue
Table 3. Ranking of Global Top TB Diagnostic Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global TB Diagnostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Radiographic Method
Table 6. Key Players of Diagnostic Laboratory Methods
Table 7. Key Players of Nucleic Acid Testing
Table 8. Key Players of Phage Assay
Table 9. Key Players of Detection of Latent Infection
Table 10. Key Players of Cytokine Detection Assay
Table 11. Key Players of Detection of Drug Resistance
Table 12. Key Players of Others
Table 13. Global TB Diagnostic Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global TB Diagnostic Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global TB Diagnostic Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global TB Diagnostic Market Share by Regions (2015-2020)
Table 17. Global TB Diagnostic Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global TB Diagnostic Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. TB Diagnostic Market Growth Strategy
Table 23. Main Points Interviewed from Key TB Diagnostic Players
Table 24. Global TB Diagnostic Revenue by Players (2015-2020) (Million US$)
Table 25. Global TB Diagnostic Market Share by Players (2015-2020)
Table 26. Global Top TB Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in TB Diagnostic as of 2019)
Table 27. Global TB Diagnostic by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players TB Diagnostic Product Solution and Service
Table 30. Date of Enter into TB Diagnostic Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global TB Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 33. Global TB Diagnostic Market Size Share by Type (2015-2020)
Table 34. Global TB Diagnostic Revenue Market Share by Type (2021-2026)
Table 35. Global TB Diagnostic Market Size Share by Application (2015-2020)
Table 36. Global TB Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 37. Global TB Diagnostic Market Size Share by Application (2021-2026)
Table 38. North America Key Players TB Diagnostic Revenue (2019-2020) (Million US$)
Table 39. North America Key Players TB Diagnostic Market Share (2019-2020)
Table 40. North America TB Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 41. North America TB Diagnostic Market Share by Type (2015-2020)
Table 42. North America TB Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 43. North America TB Diagnostic Market Share by Application (2015-2020)
Table 44. Europe Key Players TB Diagnostic Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players TB Diagnostic Market Share (2019-2020)
Table 46. Europe TB Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 47. Europe TB Diagnostic Market Share by Type (2015-2020)
Table 48. Europe TB Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 49. Europe TB Diagnostic Market Share by Application (2015-2020)
Table 50. China Key Players TB Diagnostic Revenue (2019-2020) (Million US$)
Table 51. China Key Players TB Diagnostic Market Share (2019-2020)
Table 52. China TB Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 53. China TB Diagnostic Market Share by Type (2015-2020)
Table 54. China TB Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 55. China TB Diagnostic Market Share by Application (2015-2020)
Table 56. Japan Key Players TB Diagnostic Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players TB Diagnostic Market Share (2019-2020)
Table 58. Japan TB Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 59. Japan TB Diagnostic Market Share by Type (2015-2020)
Table 60. Japan TB Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 61. Japan TB Diagnostic Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players TB Diagnostic Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players TB Diagnostic Market Share (2019-2020)
Table 64. Southeast Asia TB Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia TB Diagnostic Market Share by Type (2015-2020)
Table 66. Southeast Asia TB Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia TB Diagnostic Market Share by Application (2015-2020)
Table 68. India Key Players TB Diagnostic Revenue (2019-2020) (Million US$)
Table 69. India Key Players TB Diagnostic Market Share (2019-2020)
Table 70. India TB Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 71. India TB Diagnostic Market Share by Type (2015-2020)
Table 72. India TB Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 73. India TB Diagnostic Market Share by Application (2015-2020)
Table 74. Central & South America Key Players TB Diagnostic Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players TB Diagnostic Market Share (2019-2020)
Table 76. Central & South America TB Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America TB Diagnostic Market Share by Type (2015-2020)
Table 78. Central & South America TB Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America TB Diagnostic Market Share by Application (2015-2020)
Table 80. Abbott Laboratories Company Details
Table 81. Abbott Laboratories Business Overview
Table 82. Abbott Laboratories Product
Table 83. Abbott Laboratories Revenue in TB Diagnostic Business (2015-2020) (Million US$)
Table 84. Abbott Laboratories Recent Development
Table 85. Abbott Company Details
Table 86. Abbott Business Overview
Table 87. Abbott Product
Table 88. Abbott Revenue in TB Diagnostic Business (2015-2020) (Million US$)
Table 89. Abbott Recent Development
Table 90. Becton Dickinson and Company Company Details
Table 91. Becton Dickinson and Company Business Overview
Table 92. Becton Dickinson and Company Product
Table 93. Becton Dickinson and Company Revenue in TB Diagnostic Business (2015-2020) (Million US$)
Table 94. Becton Dickinson and Company Recent Development
Table 95. bioMrieux Company Details
Table 96. bioMrieux Business Overview
Table 97. bioMrieux Product
Table 98. bioMrieux Revenue in TB Diagnostic Business (2015-2020) (Million US$)
Table 99. bioMrieux Recent Development
Table 100. Cepheid Company Details
Table 101. Cepheid Business Overview
Table 102. Cepheid Product
Table 103. Cepheid Revenue in TB Diagnostic Business (2015-2020) (Million US$)
Table 104. Cepheid Recent Development
Table 105. F. Hoffman La Roche Company Details
Table 106. F. Hoffman La Roche Business Overview
Table 107. F. Hoffman La Roche Product
Table 108. F. Hoffman La Roche Revenue in TB Diagnostic Business (2015-2020) (Million US$)
Table 109. F. Hoffman La Roche Recent Development
Table 110. Hain Lifescience Company Details
Table 111. Hain Lifescience Business Overview
Table 112. Hain Lifescience Product
Table 113. Hain Lifescience Revenue in TB Diagnostic Business (2015-2020) (Million US$)
Table 114. Hain Lifescience Recent Development
Table 115. Hologic Corporation Business Overview
Table 116. Hologic Corporation Product
Table 117. Hologic Corporation Company Details
Table 118. Hologic Corporation Revenue in TB Diagnostic Business (2015-2020) (Million US$)
Table 119. Hologic Corporation Recent Development
Table 120. Thermo Fisher Scientific Company Details
Table 121. Thermo Fisher Scientific Business Overview
Table 122. Thermo Fisher Scientific Product
Table 123. Thermo Fisher Scientific Revenue in TB Diagnostic Business (2015-2020) (Million US$)
Table 124. Thermo Fisher Scientific Recent Development
Table 125. Qiagen Company Details
Table 126. Qiagen Business Overview
Table 127. Qiagen Product
Table 128. Qiagen Revenue in TB Diagnostic Business (2015-2020) (Million US$)
Table 129. Qiagen Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global TB Diagnostic Market Share by Type: 2020 VS 2026
Figure 2. Radiographic Method Features
Figure 3. Diagnostic Laboratory Methods Features
Figure 4. Nucleic Acid Testing Features
Figure 5. Phage Assay Features
Figure 6. Detection of Latent Infection Features
Figure 7. Cytokine Detection Assay Features
Figure 8. Detection of Drug Resistance Features
Figure 9. Others Features
Figure 10. Global TB Diagnostic Market Share by Application: 2020 VS 2026
Figure 11. Hospitals Case Studies
Figure 12. Clinics Case Studies
Figure 13. Others Case Studies
Figure 14. TB Diagnostic Report Years Considered
Figure 15. Global TB Diagnostic Market Size YoY Growth 2015-2026 (US$ Million)
Figure 16. Global TB Diagnostic Market Share by Regions: 2020 VS 2026
Figure 17. Global TB Diagnostic Market Share by Regions (2021-2026)
Figure 18. Porter's Five Forces Analysis
Figure 19. Global TB Diagnostic Market Share by Players in 2019
Figure 20. Global Top TB Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in TB Diagnostic as of 2019
Figure 21. The Top 10 and 5 Players Market Share by TB Diagnostic Revenue in 2019
Figure 22. North America TB Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Europe TB Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. China TB Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Japan TB Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Southeast Asia TB Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. India TB Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Central & South America TB Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Bottom-up and Top-down Approaches for This Report
Figure 30. Data Triangulation
Figure 31. Key Executives Interviewed
髄膜炎診断検査の世界市場（～2026年） Inflammation to the meninges is known as meningitis. Most common cause of meningitis is bacteria or virus. Other causes include certain illness, medications or suffering from some other disease such as tuberculosis, or HIV (Human Immunodeficiency Virus). The testing for meningitis can be done using …- 風疹診断検査の世界市場（～2026年） Rubella infection generally affects children and adults. This infection has a serious effect on pregnant women and may result in fetal death or congenital defects. Geographically, the entire rubella diagnostic testing market is classified into North America, Europe, Asia Pacific, Latin America and M…
- 豚診断検査の世界市場（～2026年） Swine diagnostic testing is extremely important for pork breeders to keep adverse effects on production and minimum economic losses. Growing consumption of pork meat is expected to be the prime factor driving the growth of global swine diagnostic testing market. Market Analysis and Insights: Global …
- 酸化ストレス検出の世界市場（～2026年） Oxidative stress is a state of imbalance caused in cells when a free radical or a reactive oxygen species takes an electron from a molecule and causes a chain reaction leading to cell and tissue damage. Within the pharmaceutical industry, biopharmaceutical and biotechnology sectors are the primary u…
- 免疫タンパク質診断検査の世界市場（～2026年） Immunoprotein is an immunologically active protein, which provides immunity against pathogenic organisms or substances. These proteins form the integrated body system of tissues, organs, cells, or cell products that neutralize antigens. They enable the diagnosis of various diseases, such as cardiova…